Your session is about to expire
← Back to Search
High-Dose Vitamin C + Chemotherapy for Pancreatic Cancer
Study Summary
This trial is testing whether adding high doses of vitamin C to the standard treatment for pancreatic cancer can improve outcomes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 4 trial • 143 Patients • NCT02151149Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Ascorbate group
- Group 2: Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the scope of the current cohort engaged in this trial?
"Affirmative. Data hosted on clinicaltrials.gov verifies that this medical experiment, which originally went live on November 28th 2018, is actively recruiting. Approximatively 65 patients need to be enlisted from a single health centre."
What risks accompany administration of nab-paclitaxel?
"Nab-paclitaxel's safety has been established in some capacity, so it was assigned a rating of 2. However, there is yet to be clinical proof that this drug can effectively treat the target condition."
Are there any other studies that have utilized nab-paclitaxel as a therapeutic agent?
"At present, there are 1158 clinical trials for nab-paclitaxel currently in progress with 329 of them entering Phase 3. These experiments span the globe with locations in Shanghai, Beijing and 59856 other cities."
What diseases or illnesses can nab-paclitaxel be employed to alleviate?
"nab-paclitaxel is typically utilized for the remediation of iron deficiency anemia. It can likewise be employed to mitigate conditions like vitamin a lack, locally advanced pancreatic adenocarcinoma, and metastatic melanoma."
Are there any spaces available in this research project?
"Clinicaltrials.gov confirms that this medical research is currently enrolling participants, with the first posting dating to November 28th 2018 and an update occurring on July 7th 2022."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger